Jacobs Levy Equity Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Jacobs Levy Equity Management's ASND Position: Q3 2026 in Review
Jacobs Levy Equity Management opened a new position in Ascendis Pharma (ASND) in Q3 2026: 16,236 shares worth $3.7M. The stake represents 0.01% of the portfolio and ranks #458 among its holdings.
347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Jacobs Levy Equity Management held 16,236 shares of Ascendis Pharma worth $3.7M as of Q3 2026.
- Ascendis Pharma was a new Jacobs Levy Equity Management position in Q3 2026.
- Ascendis Pharma made up 0.01% of Jacobs Levy Equity Management's portfolio in Q3 2026, its #458 holding.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.